The Flowr Corporation Announces Receipt of EU GMP Certification at Portuguese Facility - FLOWR CORP NEW b

TORONTO, March 31, 2020 (GLOBE NEWSWIRE) -- The Flowr Corporation ((TSX.V: FLWR, OTC:FLWPF) ("Flowr" or the "Company") announced that its wholly-owned subsidiary in Europe ("Holigen") has received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its manufacturing facility in Sintra, Portugal. The GMP certification was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products. In accordance with the certification process, the Company is the process of responding to Infarmed's final queries that will demonstrate the Company's ability to continue to comply with GMP…